Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen F Eaton

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|September 3, 2020
An Integrated Hospital Protocol for Persons With Injection-Related Infections May Increase Medications for Opioid Use Disorder Use but Challenges RemainEllen F Eaton, Rachael A Lee, Andrew O Westfall, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2019
Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ARTEllen F Eaton, Ashutosh Tamhane, Thibaut Davy-Mendez, et al.
Journal of Substance Use and Addiction Treatment|May 12, 2024
Perspectives on benefits and risks of creation of an "injection drug use" billing codeGayathri Sundaram, Taisuke Sato, David Goodman-Meza, et al.
BMC Health Services Research|July 15, 2022
Expanding access to substance use services and mental health care for people with HIV in Alabama, a technology readiness assessment using a mixed methods approachEllen F Eaton, Kaylee Burgan, Greer McCollum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2018
A 9-Point Risk Assessment for Patients Who Inject Drugs and Require Intravenous Antibiotics: Focusing Inpatient Resources on Patients at Greatest Risk of Ongoing Drug UseEllen F Eaton, Ronnie E Mathews, Peter S Lane, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2023
Brief Report: Substance Use Care Continuum in Women With and Without HIV in the Southern United StatesAditi Ramakrishnan, Ayako W Fujita, C Christina Mehta, et al.
Antiviral Therapy|February 10, 2018
Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015Angela M Bengtson, Brian W Pence, Ellen F Eaton, et al.
Journal of Biomedical Semantics|June 7, 2024
Multi-task transfer learning for the prediction of entity modifiers in clinical text: application to opioid use disorder case detectionAbdullateef I Almudaifer, Whitney Covington, JaMor Hairston, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2017
The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine CareAngela M Bengtson, Brian W Pence, Katie R Mollan, et al.
Therapeutic Advances in Infectious Disease|September 11, 2023
"I know my body better than anyone else": a qualitative study of perspectives of people with lived experience on antimicrobial treatment decisions for injection drug use-associated infectionsAmy Eckland, Michael Kohut, Henry Stoddard, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|September 3, 2020
An Integrated Hospital Protocol for Persons With Injection-Related Infections May Increase Medications for Opioid Use Disorder Use but Challenges RemainEllen F Eaton, Rachael A Lee, Andrew O Westfall, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2019
Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ARTEllen F Eaton, Ashutosh Tamhane, Thibaut Davy-Mendez, et al.
Journal of Substance Use and Addiction Treatment|May 12, 2024
Perspectives on benefits and risks of creation of an "injection drug use" billing codeGayathri Sundaram, Taisuke Sato, David Goodman-Meza, et al.
BMC Health Services Research|July 15, 2022
Expanding access to substance use services and mental health care for people with HIV in Alabama, a technology readiness assessment using a mixed methods approachEllen F Eaton, Kaylee Burgan, Greer McCollum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2018
A 9-Point Risk Assessment for Patients Who Inject Drugs and Require Intravenous Antibiotics: Focusing Inpatient Resources on Patients at Greatest Risk of Ongoing Drug UseEllen F Eaton, Ronnie E Mathews, Peter S Lane, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2023
Brief Report: Substance Use Care Continuum in Women With and Without HIV in the Southern United StatesAditi Ramakrishnan, Ayako W Fujita, C Christina Mehta, et al.
Antiviral Therapy|February 10, 2018
Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015Angela M Bengtson, Brian W Pence, Ellen F Eaton, et al.
Journal of Biomedical Semantics|June 7, 2024
Multi-task transfer learning for the prediction of entity modifiers in clinical text: application to opioid use disorder case detectionAbdullateef I Almudaifer, Whitney Covington, JaMor Hairston, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2017
The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine CareAngela M Bengtson, Brian W Pence, Katie R Mollan, et al.
Therapeutic Advances in Infectious Disease|September 11, 2023
"I know my body better than anyone else": a qualitative study of perspectives of people with lived experience on antimicrobial treatment decisions for injection drug use-associated infectionsAmy Eckland, Michael Kohut, Henry Stoddard, et al.
Pageof 5